Losses of hemifield contrast sensitivity in patients with pituitary adenoma and normal visual acuity and visual field

Clinical Neurophysiology

Volumn 110, Issue 5, 1999, Pages 876-886

  Porciatti, V ^a,b   Ciavarella, P ^a   Ghiggi, M R ^a   D'Angelo, V ^a   Padovano, S ^a   Grifa, M ^a   Moretti, G ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b CNR   (Italy)

Author keywords

Contrast sensitivity; Magnocellular pathway; Parvocellular pathway; Pituitary adenoma

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MALE; OPTIC CHIASM; PRIORITY JOURNAL; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; VISUAL STIMULATION; VISUAL SYSTEM;

ADENOMA; ADULT; AGED; CONTRAST SENSITIVITY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PHOTIC STIMULATION; PITUITARY NEOPLASMS; VISUAL ACUITY; VISUAL FIELDS;

EID: 0032973635     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-2457(99)00024-3     Document Type: Article

References (43)

1. Asa S.L., Horwath E., Kovacs K. Pituitary neoplasms: an overview of the clinical presentation, diagnosis, treatment, and pathology. Mazzaferri E.L., Saaman N.A., Endocrine tumors. 1993;77-112 Blackwell Scientific Publications, Boston.
2. Auer R.N., Alakijia P., Sutherland G.R. Asymptomatic large pituitary adenomas discovered at autopsy. Surg Neurol. 46:1996;28-31.
3. Bergland R., Ray B.S. The arterial supply of the human optic chiasm. J Neurosurg. 31:1969;327-334.
4. Bodis-Wollner I. Visual acuity and contrast sensitivity in patients with cerebral lesions. Science. 178:1972;769-771.
5. Bodis-Wollner I., Diamond S.P. The measurement of spatial contrast sensitivity in cases of blurred vision associated with cerebral lesions. Brain. 99:1976;695-710.
6. Campbell F.W., Robson J.G. On the application of Fourier analysis to the visibility of gratings. J Physiol (Lond). 197:1968;551-556.
7. Cohen A.R., Cooper P.R., Kupersmith M.J., Flamm E.S., Ransohoff J. Visual recovery after transsphenoidal removal of pituitary adenomas. Neurosurgery. 17:1985;446-452.
8. Domenici L., Trimarchi C., Piccolino M., Fiorentini A., Maffei L. Dopaminergic drugs improve human visual contrast sensitivity. Hum Neurobiol. 4:1985;195-197.
9. Elster A.D. Modern imaging of the pituitary. Radiology. 187:1993;1-4.
10. Ezzat S., Snyder P.J., Young W.F., Boyajy L.D., Newmann C., Klibanski A., Molitch M.E., Boyd A.E., Cook D.M. Octreotide treatment in acromegaly. A randomized, multicentric study. Ann Int Med. 117:1992;711-718.
11. Glaser J.S. Topical diagnosis: the optic chiasm. Glaser J.S., Neuro-ophthalmology. 1990;171-212 J.B. Lippincott, Philadelphia.
12. Goldstein J.E., Sherman J.F. Pituitary adenoma. Optom Clin. 3:1993;101-125.
13. Grochowicki M., Vighetto A., Berguet S., Sassolas G. Contrast sensitivity function and pituitary adenoma: a study of 40 cases. Br J Ophthalmol. 74:1990;358.
14. Gutowsky N.J., Heron J.R., Scase M.O. Early impairment of foveal magno- and parvocellular pathways in juxta chiasmal tumours. Vision Res. 37:1997;1401-1408.
15. Hoyt W.F., Luis O. The primate chiasm. Details of visual fiber organization studied by silver impregnation techniques. Arch Ophthalmol. 70:1963;69-85.
16. Ikeda H., Yoshimoto T. Visual disturbances in patients with pituitary adenoma. Acta Neurol Scand. 92:1995;157-160.
17. Johnston D.G., Hall K., McGregor A., Ross W.M., Kendall-Taylor P., Hall R. Bromocriptine therapy for non-functioning adenomas. Am J Med. 71:1981;1059.
18. Kucharczyk W., Davis O.D. High resolution MR imaging at 1.5 Tl. Radiology. 161:1986;761-765.
19. Kupersmith M.J., Siegel I.M., Carr R.E. Subtle disturbances of vision with compressive lesions of the anterior visual pathway measured by contrast sensitivity. Ophthalmology. 89:1982;68-72.
20. Lorance R.W., Kaufman D., Wray S.H., Mao C. Contrast visual testing in neurovisual diagnosis. Neurology. 37:1987;923-929.
21. Malarkey W.B. Prolactinomas. Mazzaferri E.L., Saaman N.A., Endocrine tumors. 1993;124-135 Blackwell Scientific Publications, Boston.
22. Merigan W.H., Katz L.M., Maunsell J.H.R. The effects of parvocellular lateral geniculate lesions on the acuity and contrast sensitivity of macaque monkeys. J Neurosci. 11:1991;994-1001.
23. Merigan W.H., Maunsell J.H.R. Macaque vision after magnocellular lateral geniculate lesions. Visual Neurosci. 5:1990;347-352.
24. Merigan W.H., Maunsell J.H.R. How parallel are the primate visual pathways? Annu Rev Neurosci. 16:1993;369-402.
25. Naito J. Retinogeniculate projection fibres in the monkey optic nerve: a demonstration of the fiber pathways by retrograde axonal transport of WGA-HRP. J Comp Neurol. 284:1989;174-186.
26. Naito J. Retinogeniculate projection fibres in the monkey optic chiasm: a demonstration of the fiber arrangement by means of wheat germ agglutinin conjugated with horseradish peroxidase. J Comp Neurol. 346:1994;559-571.
27. Plant G.T. Residual visual function in chiasmal compression. J Physiol (Lond). 360:1985;22P.
28. Plant G.T., Perry V.H. The anatomical basis of the caecocentral scotoma. Brain. 113:1990;1441-1457.
29. Poliak S.L. The vertebrate visual sustem. 1957;The University of Chicago Press, Chicago.
30. Porciatti V., Ciavarella P., Ghiggi M.R., D'Angelo V., Cascione S., Padovano S., Moretti G. Early visual dysfunction in pituitary adenomas: role of the P- and M-pathway. Invest Ophthalmol Visual Sci. 38:1997a;S7.
31. Porciatti V., Ciavarella P., Ghiggi M.R., D'Angelo V., Cascione S., Padovano S., Moretti G. Selective loss and recovery of visual function subserved by P- and M-pathway in pituitary adenomas. Electroenceph clin Neurophysiol. 103:1997b;188.
32. Reese B.E., Cowey A. The neurologic consequences of a sub-chiasmal tumor on the retino-geniculo-striate pathway of a macaque monkey. Clin Vision Sci. 4:1989;341-356.
33. Reese B.E., Cowey A. Fibre organization of the monkey's optic tract: I. Segregation of funtionally distinct axons. J Comp Neurol. 295:1990;385-400.
34. Reese B.E., Ho K.Y. Axon diameter distribution across the monkey's optic nerve. Neuroscience. 27:1988;205-214.
35. Robson J.G. Spatial and temporal contrast sensitivity function of the visual system. J Opt Soc Am. 56:1966;1141-1142.
36. Schubiger O. Radiology of pituitary adenomas. Landolt A.M., Vance M.L., Reilly P.L., Pituitary adenomas. 1996;177-219 Churchill Livingstone.
37. Shapley R. Visual sensitivity and parallel retinocortical channels. Annu Rev Psychol. 41:1990;635-658.
38. Sponsel W.E., Ritch R., Stamper R.E.J.H., Anderson D., Wilson M.R., Zimmerman T.J. Prevent blindness America visual field screening study. Am J Ophthalmol. 120:1995;699-708.
39. Trevino R. Chiasmal syndrome. J Am Opt Assoc. 66:1995;559-575.
40. Van Essen D.C., Gallant J.L. Neural mechanisms of form and motion processing in the primate visual system. Neuron. 13:1994;1-10.
41. Warnet A., Timsit J., Chanson P., Guillasseau P.J., Zamfirescu F., Harris A.G., Derome P., Chopighuh J., Lubetski J. The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas. J Neurosurg. 71:1989;687-690.
42. Webster J., Piscitelli G., Polli A., Ferrari C.I., Ismail I., Scanlon M.F. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med. 331:1994;904-999.
43. Wormington C.M. Pituitary adenoma: diagnosis and treatment. J Am Opt Assoc. 60:1989;929-935.